title: Low dose of thalidomide can be effective in advanced hepatocellular carcinoma.
authors.forename: Shin-Cherng
authors.initials: SC
authors.lastname: Chen
authors.forename: Hui-Jen
authors.initials: HJ
authors.lastname: Tsai
authors.forename: Chang-Ming
authors.initials: CM
authors.lastname: Jan
authors.forename: Yi-Hui
authors.initials: YH
authors.lastname: Wang
authors.forename: Li-Tzong
authors.initials: LT
authors.lastname: Chen
mesh_terms: D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000000981:diagnostic imaging / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D012720:Severity of Illness Index; D013792:Thalidomide / Q000008:administration & dosage* / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed
chemical_list: D007166:Immunosuppressive Agents; D013792:Thalidomide